3 Monster Stocks in the Making
Most, if not all, of the market's current mega-cap stocks started out much smaller. Investors who spotted their potential early had opportunities to make fortunes over time.
Which smaller stocks today could be monsters in the making? Here's why three Motley Fool contributors think Beam Therapeutics (NASDAQ: BEAM), CRISPR Therapeutics (NASDAQ: CRSP), and Sarepta Therapeutics (NASDAQ: SRPT) have what it takes.
Keith Speights (Beam Therapeutics): Some technologies simply have the "it factor." When you hear about them, you get the feeling that they could shake things up in a huge way. I think base editing is such a technology. And Beam Therapeutics is arguably the best base-editing stock around.
Source Fool.com
Sarepta Therapeutics Stock
€132.30
-1.560%
The community is currently still undecided about Sarepta Therapeutics with 1 Buy predictions and 0 Sell predictions.
On the other hand, the target price of 130 € is below the current price of 132.3 € for Sarepta Therapeutics, so the potential is actually -1.74%.
